© 1987 Oxford University Press
research-article |
The Relationship between Smoking and the Response to Anti-Hypertensive Treatment in Mild Hypertensives in the Medical Research Council's Trial of Treatment
MRC Epidemiology and Medical Care Centre, Northwick Park Hospital Watford Road, Harrow, Middx HAI 3UJ, UK
Present address: Department of Environmental and Preventive Medicine, The Medical College of St Bartholomew's Hospital, Charterhouse Sq, London ECIM 6BQ, UK.
The antihypertensive efficacy of propranolol in the treatment of mild hypertension was significantly impaired in cigarette smokers, whereas that of bendrofluazide was not affected by smoking habit. This diminished efficacy of propranolol in smokers may be one of several possible factors operating to reduce its primary preventive action against strokes, and possibly against coronary events.
Received 1 August 1986
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
U. Laaser and J. Breckenkamp Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol Eur J Public Health, April 1, 2006; 16(2): 217 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Feldman, N. Campbell, P. Larochelle, P. Bolli, E. D. Burgess, S. G. Carruthers, J. S. Floras, R. B. Haynes, G. Honos, F. H.H. Leenen, et al. 1999 Canadian recommendations for the management of hypertension Can. Med. Assoc. J., December 14, 1999; 161(90120): S1 - 17. [Abstract] [Full Text] [PDF] |
||||

